Insider Selling: Oscar Health, Inc. (NYSE:OSCR) COO Sells $184,253.58 in Stock

Oscar Health, Inc. (NYSE:OSCR) COO Steven Wolin sold 10,242 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $184,253.58. Following the completion of the transaction, the chief operating officer now directly owns 93,051 shares of the company’s stock, valued at $1,673,987.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Oscar Health Stock Performance

Shares of OSCR opened at $16.99 on Friday. The stock has a market capitalization of $4.03 billion, a price-to-earnings ratio of -42.48, a PEG ratio of 36.25 and a beta of 1.61. Oscar Health, Inc. has a 12 month low of $4.72 and a 12 month high of $23.44. The firm has a fifty day simple moving average of $16.98 and a 200 day simple moving average of $17.23. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company’s quarterly revenue was up 44.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.07) EPS. Research analysts forecast that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. National Bank of Canada FI acquired a new stake in shares of Oscar Health in the 4th quarter valued at approximately $1,071,000. Symmetry Peak Management LLC acquired a new stake in Oscar Health in the fourth quarter valued at $488,000. Allspring Global Investments Holdings LLC bought a new position in shares of Oscar Health in the 1st quarter valued at about $4,117,000. Assenagon Asset Management S.A. increased its stake in shares of Oscar Health by 32.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after purchasing an additional 507,009 shares during the last quarter. Finally, TD Asset Management Inc raised its holdings in shares of Oscar Health by 71.9% in the 4th quarter. TD Asset Management Inc now owns 195,600 shares of the company’s stock valued at $1,790,000 after purchasing an additional 81,800 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Piper Sandler lifted their price objective on Oscar Health from $25.00 to $28.00 and gave the company an “overweight” rating in a report on Thursday, August 8th. Robert W. Baird started coverage on shares of Oscar Health in a report on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price target for the company. Baird R W raised shares of Oscar Health to a “strong-buy” rating in a research report on Thursday, May 30th. Bank of America reaffirmed a “neutral” rating and issued a $21.00 price objective (down from $25.00) on shares of Oscar Health in a research report on Thursday, May 30th. Finally, Wells Fargo & Company increased their target price on Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Oscar Health currently has a consensus rating of “Moderate Buy” and an average target price of $24.17.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.